Portal de Periódicos da CAPES

The diabetic foot: Aetiopathogenesis and management

1993; Wiley; Volume: 9; Issue: 2 Linguagem: Inglês

10.1002/dmr.5610090204

1099-0895

Matthew J. Young, Aristidis Veves, Andrew J.M. Boulton,

Bee Products Chemical Analysis

Diabetes/Metabolism ReviewsVolume 9, Issue 2 p. 109-127 Article The diabetic foot: Aetiopathogenesis and management Matthew J. Young, Matthew J. Young University Department of Medicine, Manchester Royal Informary, Oxford Road, Manchester M13 9WL, U.K.Search for more papers by this authorAristidis Veves, Aristidis Veves University Department of Medicine, Manchester Royal Informary, Oxford Road, Manchester M13 9WL, U.K.Search for more papers by this authorAndrew J. M. Boulton, Andrew J. M. Boulton University Department of Medicine, Manchester Royal Informary, Oxford Road, Manchester M13 9WL, U.K.Search for more papers by this author Matthew J. Young, Matthew J. Young University Department of Medicine, Manchester Royal Informary, Oxford Road, Manchester M13 9WL, U.K.Search for more papers by this authorAristidis Veves, Aristidis Veves University Department of Medicine, Manchester Royal Informary, Oxford Road, Manchester M13 9WL, U.K.Search for more papers by this authorAndrew J. M. Boulton, Andrew J. M. Boulton University Department of Medicine, Manchester Royal Informary, Oxford Road, Manchester M13 9WL, U.K.Search for more papers by this author First published: July 1993 https://doi.org/10.1002/dmr.5610090204Citations: 34AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Joslin EP: The menace of diabetic grangrene. N. Engl J Med 211: 16–20, 1934. 2 Most RS and Sinnock P: The epidemiology of lower extremity amputations in diabetic individuals. Diabetes Care 6: 87–91, 1983. 3 Ebskov B and Josephsen P: Incidence of reamputation and death after gangrene of the lower extremity. Prosthet Orthotics Int 4: 77–80, 1980. 4 Bessman AN: Foot problems in diabetes. Compr Ther 8: 32–37, 1982. 5 Kozak GP and Rowbotham JL: Diabetic foot disease: a major problem. In Management of Diabetic Foot Problems, GP Kozak, and CS Hoar, Eds. W. B. Saunders, Philadelphia, 1984, pp 1–8. 6 Connor H: The economic impact of diabetic foot disease. In The Foot in Diabetes, H Connor, AJM Boulton, and JD Ward, Eds. John Wiley, Chichester, 1986, pp 145–149. 7 Assal JP, Gfeller R, and Ekoe JM: Patient education in diabetes. In Recent Trends in Diabetic Research H Boftrom, Ed. Almqvist and Wiksell International, Stockholm, 1982, pp 276–289. 8 Thomson FJ, Veves A, Ashe H, Knowles EA, Gem J, Walker MG, Hirst P, and Boulton AJM: A team approach to diabetic foot care—the Manchester experience. Foot 1: 75–82, 1991. 9 WHO/IDF: Diabetes care and research in Europe. The St Vincent Declaration. Diabetic Med 7: 360, 1990. 10 Hessett C, Moran A, and Boulton AJM. An evaluation of diabetes knowledge amongst general practitioners and senior medical students. Diabetic Med 6351–353, 1989. 11 Sussman KE, Reiber GE, and Albert SF: The diabetic foot problem—a failed system of health care? Diabetes Res Clin Prac 17: 1–8, 1992. 12 Young MJ, Conner H, and Boulton AJM: The diabetic foot 1992. Diabetic Med 9: 870–872, 1992. 13 Cochran GVB, A Primer of Orthopedic Biomechanics. Churchill Livingstone, New York, 1982, pp 268–293. 14 Melton LJ and Dyck PJ: Clinical features of the diabetic neuropathies: epidemiology. In Diabetic Neuropathy, PJ Dyck, PK Thomas, AK Asbury, AI Winegrad and D Porte, Eds. W. B. Saunders, Philadelphia, 1987, pp 27–35. 15 Pirat J: Diabetes mellitus and its degenerative complications: a prospective study of 4400 patients observed between 1947 and 1973. Diabetes Care 1: 168–188, 1978. 16 Young MJ, Boulton AJM, Macleod AF, Williams DDR, and Sonksen PH: A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 36: 150–154, 1993. 17 Thomas PK and Brown MJ: Diabetic polyneuropathy. In Diabetic Neuropathy, PJ Dyck, PK Thomas, et al. Eds. W. B. Saunders, Philadelphia, 1987, pp 56–65. 18 Cavanagh PR, Young MJ, Adams JE, Vickers KL, and Boulton AJM: Correlates of structure and function in the diabetic foot. Diabetologia 34 (Suppl 2): A39, 1991. 19 Boulton AJM: The diabetic foot. Med Clin North Am 72: 1513–1530, 1988. 20 Cavanagh PR, Derr JA, Ulbrecht JS, Maser RE, and Orchard TJ: Problems with gait and posture in neuropathic patients with insulin dependent diabetes mellitus. Diabetic Med 9: 469–474, 1992. 21 Gilmore JE, Allen JA, and Hayes JR: Autonomic function in neuropathic diabetic patients with foot ulceration. Diabetes Care 16: 61–67, 1993. 22 Ryder REJ, Marshall R, Johnson K, Ryder AP, Owens DR, and Hayes TM: Acetylcholine sweat spot test for autonomic denervation. Lancet i: 1303–1305, 1988. 23 Edmonds ME, Roberts VC, and Watkins PJ: Blood flow in the diabetic neuropathic foot. Diabetologia 22: 9–15, 1982. 24 Boulton AJM, Scarpello JHB, and Ward JD: Venous oxygenation in the diabetic neuropathic foot: evidence for arteriovenous shunting? Diabetologia 22: 6–8, 1982. 25 Ward JD: The diabetic leg. Diabetologia 22: 141–147, 1982. 26 Flynn MD and Tooke JE: Aetiology of diabetic foot ulceration: a role for the microcirculation? Diabetic Med 9: 320–329, 1992. 27 Sandemann DD, Shore AC, and Tooke JE: Relation of skin capillary pressure in patients with insulin-dependent diabetes mellitus to complications and metabolic ontrol. N Engl J Med 327: 760–764, 1992. 28 Newrick PG, Cochrane T, Betts RP, Wards JD, and Boulton AJM: Reduced hyperaemic response under the diabetic neuropathic foot. Diabetic Med 5: 570–573. 29 Flynn MD, Boolell M, Tooke JE, and Watkins PJ: The effect of insulin infusion on capillary blood flow in the diabetic neuropathic foot. Diabetic Med 9: 630–634, 1992. 30 Ganda OP: Pathogenesis of accelerated atherosclerosis in diabetes. In Management of Diabetic Foot Problems, GP Kozak and CS Hoar, Eds. W. B. Saunders, Philadelphia, 1984, pp 17–26. 31 Uusitupa MIJ: Five year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities of lipoprotein composition in non-insulin-dependent and non-diabetic subjects. Circulation 82: 27–36, 1990. 32 Colwell JA and Halushka PV: Platelet function in diabetes mellitus. Br J Haematol 44: 521–526, 1980. 33 Juhan-Vague I, Alessi MC, and Vague P: Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherosclerosis. Diabetologia 34: 457–462, 1991. 34 Bossaler C: Impaired muscarinic endothelium dependent relaxation and cyclic guanosine 5′-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta. J Clin Invest 79: 170, 1987. 35 Colwell JA, Lopes-Virella M, and Halnshka PV: Pathogenesis of atherosclerosis in diabetus mellitus. Diabetes Care 4: 121–133, 1981. 36 Levin ME: The diabetic foot: pathophysiology, evaluation and treatment. In The Diabetic Foot, ME Levin and LW O'Neal, Eds. C. V. Mosby, St Louis, 1988, pp 1–50. 37 LoGerfo FW and Coffman JD: Vascular and microvascular disease on the foot in diabetes. N Engl J Med 311: 1615–1619, 1984. 38 Edmonds ME, Morrison N, Laws JW, and Watkins PJ: Medial arterial calcification and diabetic neuropathy. Br Med J 284: 928–930, 1982. 39 Goebel F-D and Fuessi HS: Mönckeberg's sclerosis after sympathetic denervation in diabetic and non-diabetic subjects. Diabetologia 24: 348–350, 1983. 40 Everhart JE, Pettitt DJ, Knowler WC, Rose FA, and Bennett PH: Medial arterial calcification and its association with mortality and complications of diabetes. Diabetologia 31: 16–23, 1988. 41 Lachman AS, Spray TL, Kerwin DM, Shugoll GI, and Roberts WC: Medial calcinosis of Mönckeberg. A review of the problem and a description of a patient with involvement of peripheral, visceral and coronary arteries. Am J Med 63: 615–622, 1977. 42 Nillson SE, Lindholm H, Bülow S, Frostberg N, Emilsson T, and Stenkula G: The Kristianstad survey 63–64 (calcifications in arteries of lower limbs). Acta Med Scand 42 (Suppl): 1–46, 1967. 43 Janka HU, Stadl E, and Mehnert H: Peripheral vascular disease in diabetes mellitus and its relation to cardiovascular risk factors: screening with Doppler ultrasonic technique. Diabetes Care 3: 207–213, 1980. 44 Jensen T, Borch-Johnsen K, Kofoed-Enevoldsen A, and Deckert T: Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic enphropathy: incidence and risk factors. Diabetologia 30: 144–148, 1987. 45 Young MJ, Adams JE, Anderson GF, Boulton AJM, and Cavanagh PR: Medial arterial calcification in the feet of diabetic patients and matched non-diabetic control subjects. Diabetologia 36: 615–621, 1993. 46 Cutajar CL, Marston A, and Newcombe JF: Value of cuff occlusion pressures in assessment of peripheral vascular disease. Br Med J 2: 392–395, 1973. 47 Emanuele MA, Buchanan BJ, and Abraira C: Elevated leg systolic pressures and arterial calcification in diabetic occlusive vascular disease. Diabetes Care 4: 289–292, 1981. 48 J Dormandy (Ed.): European Consensus Document on Critical Limb Ischaemia. Springer-Verlag, Berlin, 1989. 49 Larkin JG and Frier EM: Limited joint mobility and Dupuytrens contracture in diabetic, hypertensive and normal populations. Br Med J 292: 1494, 1986. 50 Goodfield MJB and Millard LG: The skin in diabetes mellitus. Diabetologia 31: 567–575, 1988. 51 Lundbaek K: Stiff hands in long term diabetes. Acta Med Scand 158: 447P–451, 1957. 52 Rosenbloom AL, Silverstain JM, Lezotte DC, Richardon K, and McCallum M: Limited joint mobility in childhood diabetes indicates increased risk for microvascular disease. N Engl J Med 305: 191–194, 1981. 53 Campbell RR, Hawkins SJ, Maddison PJ, and Rickless JPD: Limited joint mobility in the diabetes mellitus. Ann Rheum Dis 44: 93–97, 1985. 54 Delbridge L, Perry P, Marr S, Arnold N, Yue DK, Turtle JR, and Reeve TS: Limited joint mobility in the diabetic foot: relationship to neuropathic ulceration. Diabetic Med 5: 333–337, 1988. 55 Fernando DJS, Masson EA, Veves A, and Boulton AJM: Relationship of limited joint mobility to abnormal foot pressures and diabetic foot ulceration. Diabetes Care 14: 8–11, 1991. 56 Young MJ, Cavanagh PR, Thomas G, Johnson MM, Murray H, and Boulton AJM: The effect of callus removal on dynamic plantar foot pressures in diabetic patients. Diabetic Med 9: 55–57, 1992. 57 Veves A, Fernando DJS, Walewski P, and Boulton AJM: A study of plantar pressures in a diabetic clinic population. Foot 1: 89–92, 1991. 58 Cavanagh PR, Sims DS Jr., and Sanders LJ: Body mass is a poor predictor of peak plantar pressure in diabetic men. Diabetes Care 14: 750–755, 1991. 59 Brand PW: Repetitive stress in the development of diabetic foot ulcers. In The Diabetic Foot, ME Levin and LW O'Neal, Eds. C V Mosby, St. Louis, 1988, pp 83–90. 60 Masson EA, Hay EM, Stockley I, Veves A, Betts RP, and Boulton AJM: Abnormal foot pressures alone may not cause ulceration. Diabetic Med 6: 426–428, 1989. 61 Silvino N, Evanski PM, and Waugh TR: The Harris and Beath footprinting mat: diagnostic validity and clinical use. Clin Orthop Relat Res 151: 265–269, 1980. 62 Barrett JP and Mooney V: Neuropathy and diabetic pressure lesions. Orthop Clin North Am 4: 43–47, 1973. 63 Stokes IAF, Furis IB, and Hutton WC: The neuropathic ulcer and loads on the foot in diabetic patients. Acta Orthop Scand 46: 839–847, 1976. 64 Ctercteko GC, Dhanendran M, Hutton WC, and LeQuesne LP. Vertical forces acting on the feet of diabetic patients with neuropathic ulceration. Br J Surg 68608–614, 1981. 65 Chodera J: Examination methods of standing in man. F U Czech Acad Sci 1957; Volumes 1–3. 66 Betts RP, Franks CI, and Duckworth T: Analysis of pressures and loads under the foot. 1. Quantification of the static distribution using the PET computer. 2. Quantification of the dynamic distribution. Clin Phys Physiol Mens 1: 101–124, 1980. 67 Cavanagh PR and Ulbrecht JS: The diabetic foot: a quantitative approach to the assessment of neuropathy, deformity, and plantar pressure. In Disorders of the Foot, 2nd ed., M Jahss, Ed. W. B. Saunders, New York, 1991, pp 1864–1907. 68 Young MJ, Murray HJ, Veves A, and Boulton AJM: A comparison of the Musgrave and optical pedobarograph systems for measuring foot pressures in diabetic patients. The Foot 3: 62–64, 1993. 69 Boulton AJM, Hardisty CA, Betts RP, Franks CI, Worth RC, Ward JD, and Duckwork T: Dynamic foot pressure and other studies as diagnostic and management aids in diabetic neuropathy. Diabetes Care 6: 26–33, 1983. 70 Veves A, Murray HJ, Young MJ, and Boulton AJM: The risk of foot ulceration in diabetic patients with high foot pressure: a prospective study. Diabetologia 35: 660–663, 1992. 71 Wilson RM: Neutrophil function in diabetes. Diabetic Med 6: 509–512, 1986. 72 Pecoraro RE, Ahroni JH, Boyko EJ, and Stensel VL: Chronology and determinants of tissue repair in diabetic lower-extremity ulcers. Diabetes 40: 1305–1313, 1991. 73 Louie TJ, Gartlett JG, and Tally FP: Aerobic and anaerobic bacteria in diabetic foot ulcers. Ann Intern Med 85: 461–463, 1976. 74 Fernando DJS, Hutchison A, Veves A, Gokal R, and Boulton AJM: Risk factors for non-ischaemic foot ulceration in diabetic nephropathy. Diabetic Med 8: 223–225, 1991. 75 Veves A, Van Ross ERE, and Boulton AJM: Foot pressure measurements in diabetic and non-diabetic amputees. Diabetes Care 15: 905–907, 1992. 76 Delbridge L, Appleberg M, and Reeves TS: Factors associated with the development of foot lesions in the diabetic. Surgery 93: 78–82, 1983. 77 Young RJ, Zhou YQ, Rodriguez E, Prescott RJ, Ewing DJ, and Clark BF: Variable relationship between peripheral somatic and autonomic neuropathy in patients with different syndromes of diabetic polyneuropathy. Diabetes 35: 192–197, 1986. 78 Pecoraro RE, Reiber GE, and Burgess EM: Pathways to diabetic limb amputation: basis for prevention. Diabetes Care 13: 513–521, 1990. 79 Walsh CH, Soler NG, Fitzgerald MG, and Malins JM: Association of foot lesions with retinopathy in patients with newly diagnosed diabetes. Lancet i: 878–880, 1975. 80 Edmonds ME, Blundell MP, Morris HE, Maelor-Thomas E, Cotton LT, and Watkins PJ: Improved survival of the diabetic foot: the role of the specialist foot clinic. Q J Med 232: 763–771, 1986. 81 Wagner FW: The dysvascular foot: a system for diagnosis and treatment. Foot Ankle 2: 64, 1981. 82 Cohen SJ: Potential barriers to diabetes care. Diabetes Care 6: 499–500, 1983. 83 Bailey TS, Yu HM, and Rayfield EJ: Patterns of foot examination in a diabetes clinic. Am J Med 78: 371–374, 1985. 84 Kumar S, Fernando DJS, Veves A, Knowleds A, Young MJ, and Boulton AJM: Semmes-Weinstein monofilaments: a simple, effective and inexpensive screening device for identifying diabetic patients at risk of foot ulceration. Diabetes Res Clin Practice 13: 63–67, 1991. 85 Young MJ, Manes C, and Boulton AJM: Vibration perception predicts foot ulceration: a prospective study. Diabetic Med 9 (Suppl 2): P75, 1992. 86 Ewing DJ, Martyn CN, Young RJ, and Clarke BF: The vlaue of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 8: 491–498, 1985. 87 Masson EA and Boulton AJM: Aldose reductase inhibitor in the treatment of diabetic neuropathy. A review of the rationale and clinical evidence. Drugs 39: 190–202, 1990. 88 Boulton AJM, Levin S, and Comstock J: A multicentre trial of the aldose reductase inhibitor, tolrestat, in patients with symptomatic diabetic neuropathy. Diabetologia 33: 431–437, 1990. 89 Giugliano D, Marfella R, Quatraro A, De Rosa N, Salvatore T, Cozzolino D, Ceriello A, and Torella R: Tolrestat for mild diabetic neuropathy. Ann Intern Med 118: 7–11, 1993. 90 The gamma-linoleic acid multicentre trial group: Treatment of diabetic neuropathy with gamma-linoleic acid. Diabetes Care 16: 8–15, 1993. 91 Barth R, Campbell LV, Allen S, Jupp JJ, and Chisholm DJ: Intensive education improves knowledge, compliance, and foot problems in type 2 diabetes. Diabetic Med 8: 111–117, 1991. 92 Knowles EA, Kumar S, Veves A, Young MJ, Fernando DJS, and Boulton AJM: Essential elements of footcare education are retained for at least a year. Diabetic Med 9 (Suppl 2): P8, 1992. 93 Gibbons GW and Freeman D: Vascular evaluation and treatment of the diabetic. Clin Podiatr Med Surg 4: 377–381, 1987. 94 Edelstein D and Brownless M.: Mechanistic studies of advanced glycation end product inhibition by aminoguanidine. Diabetes 42: 26–29, 1992. 95 Young MJ, Taylor PM, and Boulton AJM: A new, non-invasive technique to predict foot ulcer risk. Diabetes 42 (Suppl 1): A632, 1993. 96 Tovey FE.: The manufacture of diabetic footwear. Diabetic Med 1: 69–71, 1984. 97 Tovey FE and Moss MJ: Specialist shoes for the diabetic foot. In The Foot in Diabetes, H Connor, AJM Boulton, and JD Ward, Eds. John Wiley, Chichester, 1987, pp 97–108. 98 Veves A, Masson EA, Fernando DJS, and Boulton AJM: Use of experimental padded hosiery to reduce foot pressures in diabetic neuropathy. Diabetes Care 12: 635–655, 1989. 99 Veves A, Masson EA, Fernando DJS, and Boulton AJM: Studies of experimental hosiery in diabetic neuropathic patients with high foot pressures. Diabetic Med 7: 324–326, 1990. 100 Gudas CJ: Prophylactic surgery in the diabetic foot. Clin Pod Med Surg 4: 445–448, 1987. 101 Rosen RC, Davids MS, and Bohanski LM: Hemorrhage into plantar callus and diabetes mellitus. Cutis 35: 339–341, 1985. 102 Harkless LB: You see what you look for and recognise what you know. Clin Pod Med Surg 4: 331–339, 1987. 103 Masson EA, Angle S, Roseman P, Soper C, Wilson I, Cotton M, and Boulton AJM: Diabetic foot ulcers—do patients know how to protect themselves? Prac Diabetes 6: 22–23, 1989. 104 Boulton AJM: The diabetic foot. Med Clin North Am 72: 1513–1530, 1988. 105 Boulton AJM: The diabetic foot: neuropathic in aetiology? Diabetic Med 7: 852–858, 1990. 106 Pollard JP and Le Quesne LP: Method of healing diabetic forefoot ulcers. Br Med J 286: 436–437, 1983. 107 Burden AC, Jones GR, Jones R, and Blandford RL: Use of the “Scotchcast boot” in treating diabetic foot ulcers. Br Med J 186: 1555–1557, 1983. 108 Mueller MJ, Diamond JE, and Sinacore DR: Total contact casting in treatment of diabetic plantar ulcers. Diabetes Care 12: 384–388, 1989. 109 Stipa S and Wheelcock FC: A comparison of femoral artery grafts in diabetic and non-diabetic patients. Am J Surg 121: 223–228, 1971. 110 Joseph WS and Axler DA: Microbiology and antimicrobial therapy of diabetic foot infections. Clin Pod Med Surg 7: 467–481, 1990. 111 Porter M: Making sense of dressings. Wound Manage 2: 10–12, 1992. 112 Lithner F: (Letter). Diabetes Care 13: 814–815, 1990. 113 Knowles EA, Personal communication. 114 Tovey FE: Diabetic foot ulceration. Wound Manage 3: 12–14, 1993. 115 Greenwood D: Honey for superficial wounds and ulcers. Lancet 341: 90–91, 1993. 116 Zumla A and Lulat A: Honey: a remedy rediscovered. J R Soc Med 82: 374–375, 1989. 117 Knighton DR, Ciresi K, Fiegel VD, Schumerth S, Butler E, and Cerra F: Stimulation of repair in chronic, non-healing cutaneous ulcers using platelet-derived wound healing formula. Surg Gynecol Obstet 170: 56–60, 1990. 118 Krupski WC, Reilly LM, Perez S, Moss KM, Crombleholm PA, and Rapp JH: A prospective randomized trial of autologous platelet-derived wound healing factors for the treatment of chronic nonhealing wounds: a preliminary report. J Vasc Surg 14: 526–536, 1991. 119 Robson MC, Phillips LG, Thomasen A, Robson LE and Pierce GF: Platelet-derived growth factor BB for the treatment of chronic pressure ulcers. Lancet 339: 23–25, 1992. 120 Young MJ, Larsen J, Knowles A, Parnell L, Ward JD, and Boulton AJM: The treatment of diabetic neuropathic foot ulcers with biosynthetic platelet derived growth factor. Diabetic Med 9 (Suppl 2): P76, 1992. 121 Day JL: Patient education—how may recurrence be prevented? In The Foot in Diabetes, H Connor and AJM Boulton, Eds. John Wiley, Chichester, 1987, pp 135–143. 122 Hetherington VJ: Technetium and combined gallium and technetium scans in the neurotrophic foot. J Am Podiatr Assoc 72: 458–463, 1982. 123 Levin S: Digest of current literature. Infect Dis Clin Pract 1: 49–50, 1992. 124 McKeown KC: The history of the diabetic foot. In The Diabetic Foot, 2nd ed., AJM Boulton, H Connor, and PR Cavanagh, Eds. John Wiley, Chichester (in press) 1994. 125 Hunt JA: Foot infections are rarely due to a single microorganism. Diabet Med 9: 749–752, 1992. 126 Turner TD: Hydrogels and hydrocolloids—an overview of the products and their properties. In Advances in Wound Management, TD Turner, RJ Schmidt, and KG Harding, Eds. John Wiley, Chichester, 1985, pp 89–95. 127 Edmonds M, Foster A, Greenhill M, Sinha J, Philpott-Howard J, and Salisbury J: Acute septic vasculitis not diabetic microangiopathy leads to digital necrosis in the neuropathic foot. Diabetic Med 9 (Suppl 1): P85, 1992. 128 Goldner MG: The fate of the second leg in the diabetic amputee. Diabetes 9: 100–103, 1960. 129 Charcot JM: On some neuropathies apparently related to a lesion of the brain or spinal cord (translated by Hoche G, and Sanders LJ). J Hist Neurosci 1: 75–87, 1992. 130 Jordan WR: Neuritic manifestations in diabetes mellitus. Arch Intern Med 57: 307–310, 1936. 131 Sinha S, Munichoodappa CS, and Kozak GP: Neuroarthropathy (Charcot joints) in diabetes mellitus. Medicine (Baltimore) 51: 191–121, 1972. 132 Cofield RH, Morrison MJ, and Beabout JW: Diabetic neuroarthropathy in the foot: patient characteristics and patterns of radiographic change. Foot Ankle 4: 15–22, 1983. 133 Sammarco GJ: Diabetic arthropathy. In The Foot in Diabetes, GJ Sammarco, Ed. Lea and Fabiger, Philadelphia, 1991 pp 153–172. 134 Fryckberg RG: Osteoarthropathy. Clin Podiatr Med Surg 4: 351–376, 1987. 135 Sanders LJ and Frykberg RG: Charcot foot. In The Diabetic Foot, 5th ed., ME Levin, LW O'Neal, and JH Bowker, Eds. Mosby Year Books, St Louis, 1993, pp 149–180. 136 Pogonowska MJ, Collins LC, and Dobson HL: Diabetic osteopathy. Radiology 89: 265–271, 1967. 137 Cavanagh PR, Young MJ, Adams JE, Vickers KL, and Boulton AJM: Bony abnormalities in the feet of neuropathic diabetic patients. Diabetes Care. (in press), 1993. 138 Clohisy DR and Thompson RC: Fractures associated with neuropathic arthropathy in adults who have juvenile-onset diabetes. J Bone Jt Surg 70A: 1192–1200, 1988. 139 Stevens MJ, Edmonds ME, Foster AVM, and Watkins PJ: Selective neuropathy and preserved vascular responses in the diabetic Charcot foot. Diabetologia 35: 148–154, 1992. 140 Marshall A, Young MJ, and Boulton AJM: The neuropathy of patients with Charcot feet: is there a specific deficit? Diabetic Med 10 (Suppl 1): P101, 1993. 141 McEnery KW, Gilula LA, Hardy DC, and Staple TW: Imaging of the diabetic foot. In The Diabetic Foot, 5th ed., ME Levin, LW O'Neal, and JH Bowker, Eds. Mosby Year Books, St Louis, 1993, pp 341–364. 142 Johnson JTH: Neuropathic fractures and joint injuries. Pathogenesis and rationale of prevention and treatment. J Bone J Surg 49A: 1–30, 1967. 143 Connolly JF and Jacobsen FS: Rapid bone destruction after a stress fracture in a diabetic (Charcot) foot. Nebr Med J 70: 438–440, 1985. 144 Edelman SV, Kosofsky EM, Paul RA, and Kizak GP: Neuro-osteoarthropathy (Charcot's joints) in diabetes mellitus following revascularisation surgery: three case reports and a review of the literature. Arch Intern Med 147: 1504–1508, 1987. 145 Edmonds ME, Clark MB, Newton S, Barrett J, and Watkins PJ: Increased uptake of bone radiopharmaceutical in diabetic neuropathy. Q J Med 57: 843–855. 146 Eichenholtz SN, Charcot Joints. Charles C. Thomas, Springfield, IL, 1966. 147 Keenan AM, Tindell NL, and Alavi A: Diagnosis of pedal osteomyelitits in diabetic patients using current scintigraphic techniques. Arch Intern Med 149: 2262–2265, 1989. 148 Lesko P and Maurer RC: Talonavicular dislocations and midfoot arthropathy in neuropathic diabetic feet: natural course and principles of treatment. Clin Orthop 240: 226, 1989. 149 Miller DS and Lichtman WF. Diabetic neuropathic arthropathy of the feet. Arch Surg 70513, 1955. 150 Sanders LJ and Frykberg RG: Diabetic neuropathic osteoarthropathy: the Charcot foot. In The High Risk Foot in Diabetes, RG Frykberg, Ed. Churchill Livingstone, New York, 1991, pp 297–338. 151 Rechman MTA, Clayson AD, Marsh D, Adams J, Canteril J, and Anderson DC: Treatment of reflex sympathic dystrophy with intravenous pamidronate. Bone 13: 116, 1992. 152 Selby PL, Young MJ, and Boulton AJM: Pamidronate—a definitive treatment for diabetic Charcot neuroarthropathy? Diabetic Med 9 (Suppl 2): A27, 1992. Citing Literature Volume9, Issue2July 1993Pages 109-127 ReferencesRelatedInformation